JointPlan News


Stem Cell Therapy

The International Society for Stem Cell Research has issued a statement that “When a professional consensus on the safety and therapeutic value of a treatment is lacking, the ISSCR believes it is unethical and unprofessional to market such interventions directly to patients”. The COA supports this statement.

Ortholink Newsletter

OrthoLink is the Foundation’s newsletter, written for people interested in building and keeping their bone and joint health.